To understand whether inhibition of PP2A abrogates the anti-tumor functions of Th9 cells, naïve CD4+ T cells from OT-II TCR transgenic mice differentiated into Th9 cells in the presence or absence of LB-100. The gene discussed is CD4; the disease is neoplasm.